1. Home
  2. PRTC vs CARE Comparison

PRTC vs CARE Comparison

Compare PRTC & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureTech Health plc

PRTC

PureTech Health plc

N/A

Current Price

$16.75

Market Cap

386.7M

Sector

Health Care

ML Signal

N/A

Logo Carter Bankshares Inc.

CARE

Carter Bankshares Inc.

HOLD

Current Price

$19.05

Market Cap

456.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTC
CARE
Founded
2015
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
386.7M
456.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRTC
CARE
Price
$16.75
$19.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.1K
74.9K
Earning Date
08-28-2025
01-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
118.48
EPS
0.20
1.36
Revenue
$6,391,000.00
$154,517,000.00
Revenue This Year
N/A
$10.69
Revenue Next Year
N/A
$14.79
P/E Ratio
$7.86
$14.02
Revenue Growth
1265.60
20.24
52 Week Low
$13.30
$13.61
52 Week High
$23.35
$20.53

Technical Indicators

Market Signals
Indicator
PRTC
CARE
Relative Strength Index (RSI) 49.77 68.28
Support Level $16.01 $18.21
Resistance Level $18.05 $19.15
Average True Range (ATR) 0.34 0.34
MACD 0.17 0.20
Stochastic Oscillator 49.02 91.98

Price Performance

Historical Comparison
PRTC
CARE

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: